Genelife Clinical Research Pvt. Ltd.

Genelife Clinical Research Pvt. Ltd. Your Trustworthy Partner in Product Development! Genelife offers an array of study management services that encompass the entire spectrum of clinical research.

Founded in 2010, Genelife Clinical Research stands as a distinguished Contract Research Organization (CRO) committed to providing a comprehensive range of Phase I-IV clinical research services to global pharmaceutical, biotech, and medical device companies. Operating across Europe, the USA, and Asia, we bring an extensive portfolio of expertise and innovative solutions to drive success in every project. Our comprehensive offerings include but are not limited to:

1. Project Management
2. Clinical Operations: Clinical Site Selection & Management, Clinical and Medical Monitoring
3. Data Management
4. Biostatistics
5. Medical Writing
6. Regulatory Services
7. Quality Audits
8. Pharmacovigilance Studies
9. Pre-Clinical Studies
10. Bio-Avalability and Equlvalance studies

With our extensive experience in clinical trial management, we stand uniquely positioned to provide unparalleled support to our sponsors. Our past accomplishments span from single-center Phase I trials to large-scale multinational Phase III trials, showcasing our versatility and depth of expertise. Genelife offers an amalgamation of performance, reliability, and demonstrated therapeutic experience that culminate in high-quality results. Our resourceful approach, coupled with a customer-centric ethos, guarantees the success of your projects. At Genelife, we don't merely provide services; we deliver outcomes that resonate. Genelife is your gateway to performance-driven solutions. With a track record of achievement, a commitment to innovation, and an unwavering dedication to client satisfaction, we are poised to deliver results that turn your projects into success stories. Join us as we embark on a journey of transformation in clinical research. Experience the Genelife difference – where excellence meets innovation, and partnership meets performance.

On World Patient Safety Day, we reaffirm that every trial must be designed around protecting participants. From risk min...
16/09/2025

On World Patient Safety Day, we reaffirm that every trial must be designed around protecting participants. From risk minimization to continuous monitoring, safety drives every decision at Genelife. Because without safety, there can be no science, and without integrity, there can be no trust.

Lymphoma may be invisible to many, but its impact on patients and families is profound. On World Lymphoma Awareness Day,...
15/09/2025

Lymphoma may be invisible to many, but its impact on patients and families is profound. On World Lymphoma Awareness Day, we spotlight the role of research in advancing new therapies. At Genelife, we bring together investigators, statisticians, and caregivers to deliver evidence that matters. Because every dataset is more than numbers—it represents a person’s hope for tomorrow.

Bioavailability/Bioequivalence studies are the bridge between innovation and affordability.They ensure that generic medi...
14/09/2025

Bioavailability/Bioequivalence studies are the bridge between innovation and affordability.
They ensure that generic medicines are safe, effective, and equivalent to innovator brands.
At Genelife, our BA/BE expertise includes:
State-of-the-art clinical units
Bioanalytical method development
Regulatory compliance (CDSCO, USFDA, EMA)
Because access to affordable medicines begins with reliable science.

Before any drug can reach humans, it must first prove its safety and effectiveness in non-clinical studies. At Genelife ...
08/09/2025

Before any drug can reach humans, it must first prove its safety and effectiveness in non-clinical studies. At Genelife Clinical Research, we partner with sponsors to deliver high-quality non-clinical research that accelerates development and supports global regulatory submissions.
Our expertise includes:
* Toxicology Studies – ensuring compounds are safe for first-in-human trials
* Pharmacokinetics / ADME Studies – understanding how the drug is absorbed, distributed, metabolized, and excreted
* Bioanalytical Method Development – robust, validated assays for precise and reliable data
These studies form the backbone of early development, laying the groundwork for successful clinical trials and approvals.
Curious how our non-clinical expertise can strengthen your program and speed time-to-market? Let’s connect and explore how we can support your journey.

🌼 Happy Onam from all of us at Genelife Clinical Research Pvt. Ltd. 🌼Onam is a festival that celebrates hope, abundance,...
04/09/2025

🌼 Happy Onam from all of us at Genelife Clinical Research Pvt. Ltd. 🌼
Onam is a festival that celebrates hope, abundance, and togetherness. Just like this season of renewal, we at Genelife remain committed to fostering trust, collaboration, and integrity in everything we do.
May this Onam bring health, prosperity, and happiness to you and your loved ones.

Wishing you peace, health, and prosperity on this blessed occasion!
04/09/2025

Wishing you peace, health, and prosperity on this blessed occasion!

We at Genelife Clinical Research Pvt. Ltd. are proud to support pharma, biotech, and academic partners with cost-effecti...
31/08/2025

We at Genelife Clinical Research Pvt. Ltd. are proud to support pharma, biotech, and academic partners with cost-effective, high-quality clinical research solutions.
Our expertise includes:
⭐ Non-clinical studies
⭐ BA/BE studies
⭐ Phase I–IV clinical trials
⭐ Medical writing & regulatory support
⭐ Data management & biostatistics
With operations across India, Nepal, Sri Lanka, and Europe, we combine global reach with local expertise to help bring products to market efficiently.
🔗 Learn more: www.genelifecr.com

✨ Happy Deepawali from Genelife Clinical Research Pvt. Ltd.! ✨As we celebrate the Festival of Lights, may this Deepawali...
31/10/2024

✨ Happy Deepawali from Genelife Clinical Research Pvt. Ltd.! ✨

As we celebrate the Festival of Lights, may this Deepawali bring new hopes, brighter days, and endless prosperity to each of you. At Genelife, we are grateful for the support and trust of our clients, partners, and dedicated team members who illuminate our journey in clinical research every day.

Let’s continue to light the way for advancements in healthcare and a healthier future for all.

Wishing you a Deepawali filled with joy, peace, and abundance. 🌟

Happy Deepawali! 🪔
hashtag hashtag

09/10/2024

With over 13 years of expertise and the successful completion of more than 50 clinical trials, Genelife Clinical Research has solidified its reputation as a leading Contract Research Organization (CRO) in the field of small molecule clinical trials. Pharmaceutical companies, from global industry lea

24/09/2024

Since its inception in 2010, Genelife Clinical Research Pvt. Ltd.

22/09/2024

The major differences between the ICH-GCP guidelines and the draft GCP proposed by the CDSCO involve several substantial updates aimed at modernizing and enhancing clinical research practices in India:
1. The draft guidelines emphasize incorporating advanced digital health technologies, such as wearables and sensors, into clinical trials to improve data collection and research methodologies. This reflects a shift towards more tech-savvy approaches in data acquisition, which includes both electronic and paper tools​.
2. There are new definitions for concepts such as e-consent and decentralized clinical trials. The draft also introduces a focus on computerized systems validation, ensuring that these systems adhere to specified standards for data management and security controls​.
3. The proposed changes update guidelines on ethics, emphasizing conflicts of interest, compensation for research-related harm, and privacy concerns. Quality assurance sections retain much of their previous content but incorporate a risk-based approach to quality management​.
4. The draft guidelines also expand to cover newer areas of research like medical devices, stem cells, and nanoparticles, and include sections on academic clinical research, marginalized communities, and enhanced sponsor oversight and monitoring​.
These updates indicate a significant effort by CDSCO to align more closely with global standards while addressing the specific local needs.

16/09/2024

In the rapidly evolving landscape of healthcare, driven by remarkable advances in pharmaceutics and biotechnology, the need for precise, expertise-driven clinical research has never been more critical. Genelife Clinical Research, a leader in the field, is at the forefront of defining the pathways fo

Address

Office No. 12, Ground Floor, Evershine Mall, Chincholi Bunder, New Link Road, Malad West
Mumbai
400064

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Website

http://www.gene-life.com/

Alerts

Be the first to know and let us send you an email when Genelife Clinical Research Pvt. Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Genelife Clinical Research Pvt. Ltd.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram